Trial Profile
Randomised, blinded clinical study to assess the immunogenicity and reactogenicity of SB Biologicals' dTpa and DTPa vaccines and a commercial Td vaccine administered as a booster dose to healthy children 4 to 6 years old, previously vaccinated with four doses of SB Biologicals' DTPa vaccine in the first two years of life
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Diphtheria-tetanus vaccine (Primary) ; DTaP vaccine (Primary) ; Pertussis acellular vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- 06 Nov 2006 New trial record.